BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3777022)

  • 1. Duchenne muscular dystrophy in a girl with a 45,X/46,XX/47,XXX chromosome constitution.
    Bortolini ER; da Silva DM; Chequer RS; Vianna-Morgante AM; Zatz M
    Am J Med Genet; 1986 Oct; 25(2):239-43. PubMed ID: 3777022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Duchenne muscular dystrophy carrier presenting with mosaic X chromosome constitution and muscular symptoms--with analysis of the barr bodies in the muscle].
    Kinoshita M; Ikeda K; Yoshimura M; Saku A; Watanabe K
    Rinsho Shinkeigaku; 1990 Jun; 30(6):643-6. PubMed ID: 2225660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xp21/autosome translocations. Case report and risk for Duchenne muscular dystrophy.
    Holden JJ; Smith A; MacLeod PM; Masotti R; Duncan AM
    Clin Genet; 1986 Jun; 29(6):516-22. PubMed ID: 3742857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duchenne muscular dystrophy in a girl with an (X;15) translocation.
    Ribeiro MC; Melaragno MI; Schmidt B; Brunoni D; Gabbai AA; Hackel C
    Am J Med Genet; 1986 Oct; 25(2):231-6. PubMed ID: 3777020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Duchenne's muscular dystrophy in a girl with 45,X/46,XX chromosomal mosaicism].
    Aver'ianov IuN; Bogomazov EA; Logunova LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(10):1449-52. PubMed ID: 930487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on genetic heterogeneity in Duchenne muscular dystrophy.
    Rabbi-Bortolini E; Zatz M
    Am J Med Genet; 1986 May; 24(1):111-7. PubMed ID: 3706399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 11. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne muscular dystrophy in a female with 45,X/46,XX chromosome constitution.
    Sano M; Saito F; Yamamoto K; Tonomura A; Tsukagoshi H
    Jinrui Idengaku Zasshi; 1987 Sep; 32(3):257-62. PubMed ID: 3448308
    [No Abstract]   [Full Text] [Related]  

  • 13. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
    Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
    J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
    Zatz M; Karp LE; Rogatko A
    Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duchenne muscular dystrophy: comparison among different racial groups.
    Bortolini ER; Zatz M
    Am J Med Genet; 1987 Dec; 28(4):925-9. PubMed ID: 3688030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum pyruvate kinase in carriers of Duochenne muscular dystrophy.
    Yamuna S; Valmikinathan K; Burt D; Emery AE
    Clin Chim Acta; 1977 Aug; 79(1):277-9. PubMed ID: 890959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
    Vainzof M; Zatz M; Otto PA
    Am J Med Genet; 1985 Sep; 22(1):81-7. PubMed ID: 4050853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.